2009
Early Neurologic Abnormalities Associated with Human T-Cell Lymphotropic Virus Type 1 Infection in a Cohort of Peruvian Children
Kendall EA, González E, Espinoza I, Tipismana M, Verdonck K, Clark D, Vermund SH, Gotuzzo E. Early Neurologic Abnormalities Associated with Human T-Cell Lymphotropic Virus Type 1 Infection in a Cohort of Peruvian Children. The Journal Of Pediatrics 2009, 155: 700-706. PMID: 19628219, PMCID: PMC2764792, DOI: 10.1016/j.jpeds.2009.05.027.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAge DistributionAge of OnsetCase-Control StudiesChildChild, PreschoolCohort StudiesConfidence IntervalsFemaleHTLV-I InfectionsHuman T-lymphotropic virus 1HumansInfectious Disease Transmission, VerticalMaleNeurologic ExaminationOdds RatioParaparesisParaparesis, Tropical SpasticPeruPrevalenceProbabilityRisk AssessmentSeverity of Illness IndexSex DistributionSpinal Cord DiseasesTime FactorsUrination DisordersConceptsParesthesia/dysesthesiaHTLV-1 infectionNeurologic abnormalitiesInfective dermatitisHTLV-1Lumbar painHuman T-cell lymphotropic virus type 1 infectionMyelopathy/tropical spastic paraparesisHuman T-cell lymphotropic virus type 1Virus type 1 infectionPeruvian childrenAbnormal neurologic findingsEarly Neurologic AbnormalitiesLower extremity hyperreflexiaStandardized neurologic examinationType 1 infectionTropical spastic paraparesisWeakness/fatigueHTLV-1 statusVirus type 1Uninfected childrenNeurologic findingsNeurologic symptomsUrinary disturbanceNeurologic examination
1999
Rapid Communication CCR5 Genotype and Resistance to Vertical Transmission of HIV-1
Philpott S, Burger H, Charbonneau T, Grimson R, Vermund S, Visosky A, Nachman S, Kovacs A, Tropper P, Frey H, Weiser B. Rapid Communication CCR5 Genotype and Resistance to Vertical Transmission of HIV-1. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1999, 21: 189-193. PMID: 10421241, DOI: 10.1097/00126334-199907010-00002.Peer-Reviewed Original ResearchConceptsHIV-1 infectionHIV-1Vertical transmissionCCR5 genotypeHIV-1 infection statusHIV-1 vertical transmissionHIV-1-infected mothersPrimary HIV-1 infectionMacrophage-tropic strainsAfrican AmericansParenteral transmissionUninfected childrenChild transmissionInfected childrenInfected mothersInfected womenDelta32 mutationCCR5 receptorInfection statusWhite childrenCCR5MothersChildrenHomozygous genotypeAdditional strategies
1995
Zidovudine for the Prevention of Vertical HIV Transmission
Rouse D, Owen J, Goldenberg R, Vermund S. Zidovudine for the Prevention of Vertical HIV Transmission. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1995, 9: 401-407. PMID: 7600108, DOI: 10.1097/00042560-199508000-00011.Peer-Reviewed Original ResearchConceptsCongenital HIV infectionZDV useHIV infectionVertical human immunodeficiency virus (HIV) transmissionHuman immunodeficiency virus (HIV) transmissionAdverse effectsVertical HIV transmissionDrug-induced complicationsQuality-adjusted life yearsMarkov cohort simulationQuality of lifeDecision analysis modelUninfected childrenZDV therapyZDV treatmentAsymptomatic HIVNeonatal exposureZidovudine administrationHIV transmissionPregnant womenLife decrementsHypothetical cohortLife yearsCohort simulationHIV